The factors associated with extensive inflammatory changes in lungs (severe pneumonia) at diagnosis COVID-19 include chronic treatment with angiotensin converting enzyme inhibitors (ACEI) (p = 0.02), while chronic treatment with active vitamin D was associated with limited changes (mild pneumonia) (p < 0.011) (Table 1). This evidence concerns the gene ACE and pneumonia.